CUZD1
Basic information
Region (hg38): 10:122832158-122846175
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUZD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 24 | 4 | 2 |
Variants in CUZD1
This is a list of pathogenic ClinVar variants found in the CUZD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-122832313-C-T | not specified | Likely benign (Feb 28, 2023) | ||
10-122832340-T-G | not specified | Uncertain significance (Feb 06, 2024) | ||
10-122832343-T-C | not specified | Uncertain significance (Dec 26, 2023) | ||
10-122832399-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
10-122833686-G-T | not specified | Uncertain significance (Aug 27, 2024) | ||
10-122833801-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
10-122833909-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
10-122834711-C-G | not specified | Uncertain significance (Nov 23, 2022) | ||
10-122834751-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
10-122834783-C-G | not specified | Uncertain significance (Dec 21, 2022) | ||
10-122834839-C-A | not specified | Uncertain significance (Mar 06, 2023) | ||
10-122834857-C-G | not specified | Uncertain significance (Aug 02, 2023) | ||
10-122834897-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
10-122834960-T-C | not specified | Likely benign (Apr 22, 2022) | ||
10-122834971-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
10-122834989-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
10-122836186-T-C | not specified | Uncertain significance (Oct 22, 2021) | ||
10-122836210-C-T | not specified | Likely benign (Jul 09, 2021) | ||
10-122836231-A-T | not specified | Uncertain significance (Jul 13, 2021) | ||
10-122836318-C-T | not specified | Uncertain significance (May 20, 2024) | ||
10-122836335-G-A | not specified | Uncertain significance (May 24, 2024) | ||
10-122836347-G-T | not specified | Uncertain significance (Oct 29, 2021) | ||
10-122836358-GA-G | not specified | Benign (Mar 29, 2016) | ||
10-122836358-GAA-G | not specified | Benign (Mar 29, 2016) | ||
10-122836834-T-G | not specified | Uncertain significance (Oct 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CUZD1 | protein_coding | protein_coding | ENST00000368904 | 9 | 47482 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.29e-11 | 0.243 | 125671 | 0 | 77 | 125748 | 0.000306 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.580 | 287 | 316 | 0.908 | 0.0000155 | 3987 |
Missense in Polyphen | 91 | 108.27 | 0.84051 | 1400 | ||
Synonymous | -0.343 | 123 | 118 | 1.04 | 0.00000614 | 1162 |
Loss of Function | 0.877 | 19 | 23.6 | 0.805 | 0.00000115 | 316 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000594 | 0.000594 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00109 | 0.00109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000303 | 0.000299 |
Middle Eastern | 0.00109 | 0.00109 |
South Asian | 0.000169 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: CUZD1 antiserum inhibits cell attachment and proliferation of ovarian cancer cells so may be involved in these processes. May also play a role in the uterus during late pregnancy and/or in trypsin activation in pancreatic acinar cells. {ECO:0000250|UniProtKB:P70412, ECO:0000269|PubMed:15184879}.;
- Pathway
- cadmium induces dna synthesis and proliferation in macrophages
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.602
- rvis_EVS
- 0.65
- rvis_percentile_EVS
- 84.12
Haploinsufficiency Scores
- pHI
- 0.0850
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.162
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cuzd1
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- substrate-dependent cell migration, cell attachment to substrate;cell cycle;cell population proliferation;trypsinogen activation;cell division
- Cellular component
- integral component of membrane;transport vesicle membrane;zymogen granule membrane
- Molecular function